Literature DB >> 33450971

The Level of Lymphedema Awareness among Women with Breast Cancer in the Kingdom of Saudi Arabia.

Fatmah Alsharif1, Wedad Almutairi2, Faygah Shibily1, Fatmah Alhothari1, Fidaa Batwa1, Nidaa Batwa1, Lujain Alharbi1.   

Abstract

BACKGROUND: Lymphedema is a condition in which excessive fluid accumulates in soft tissues. It is a common complication of breast cancer treatments. It can lead to serious consequences and interfere with the activity of daily living. This study aimed to determine the level of awareness of breast-cancer-related lymphedema (BCRL) among women with breast cancer in the Kingdom of Saudi Arabia. This was a descriptive quantitative cross-sectional design that included a convenience sample of women diagnosed with breast cancer in the Kingdom of Saudi Arabia. Data were collected by distributing a self-administrated online questionnaire consisting of four parts, including demographic data (five items), the status of education about BCRL (three items), basic medical history of breast cancer (six items), and BCRL level of awareness of risk factors and management (nine items).
RESULTS: In total, 95 out of 135 of participants did not know about lymphedema, 119 of the participants (88.1%) did not receive any explanation about the possibility of lymphedema from their medical team before surgery, and 121 of them (89.6%) did not receive it after surgery. The most significant factor affecting participants' level of awareness regarding BCRL was the lack of information about the possibility of BCRL occurrence, which was not provided to them by the medical team. RECOMMENDATION: Early and continuous education for future management is essential to prevent problems related to BCRL and improve quality of life.

Entities:  

Keywords:  breast-cancer-related lymphedema; level of awareness; lymphedema

Year:  2021        PMID: 33450971      PMCID: PMC7828393          DOI: 10.3390/ijerph18020627

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  23 in total

1.  The lived experience of breast cancer-related lymphoedema.

Authors:  M Hare
Journal:  Nurs Stand       Date:  2000 Nov 1-7

Review 2.  The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology.

Authors: 
Journal:  Lymphology       Date:  2013-03       Impact factor: 1.286

3.  Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.

Authors:  Jane M Armer; Karla V Ballman; Linda McCall; Nathan C Armer; Yuanlu Sun; Tipparat Udmuangpia; Kelly K Hunt; Elizabeth A Mittendorf; David R Byrd; Thomas B Julian; Judy C Boughey
Journal:  Support Care Cancer       Date:  2018-07-06       Impact factor: 3.603

Review 4.  Risk factors of arm lymphedema in breast cancer patients.

Authors:  Z Kocak; J Overgaard
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

5.  Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study.

Authors:  B Clark; J Sitzia; W Harlow
Journal:  QJM       Date:  2005-04-08

Review 6.  Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment.

Authors:  Brian D Lawenda; Tammy E Mondry; Peter A S Johnstone
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

7.  Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system.

Authors:  Marilyn L Kwan; Ling Shen; Julie R Munneke; Emily K Tam; Paula N Partee; Mary André; Susan E Kutner; Carol P Somkin; Lynn M Ackerson; Saskia R J Thiadens
Journal:  Breast Cancer Res Treat       Date:  2012-08-19       Impact factor: 4.872

Review 8.  Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review.

Authors:  Electra D Paskett; Julie A Dean; Jill M Oliveri; J Phil Harrop
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

9.  Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.

Authors:  Daniella M F Paiva; Vivian O Rodrigues; Marcelle G Cesca; Pamella V Palma; Isabel C G Leite
Journal:  BMC Womens Health       Date:  2013-02-13       Impact factor: 2.809

10.  Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery.

Authors:  Sarah A McLaughlin; Sanjay Bagaria; Tammeza Gibson; Michelle Arnold; Nancy Diehl; Julia Crook; Alexander Parker; Justin Nguyen
Journal:  J Am Coll Surg       Date:  2012-12-21       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.